280 related articles for article (PubMed ID: 35465267)
1. The Dysregulation of SOX Family Correlates with DNA Methylation and Immune Microenvironment Characteristics to Predict Prognosis in Hepatocellular Carcinoma.
Qin S; Liu G; Jin H; Chen X; He J; Xiao J; Qin Y; Mao Y; Zhao L
Dis Markers; 2022; 2022():2676114. PubMed ID: 35465267
[TBL] [Abstract][Full Text] [Related]
2. The comprehensive expression and functional analysis of m6A modification "readers" in hepatocellular carcinoma.
Qin S; Liu G; Jin H; Chen X; He J; Xiao J; Qin Y; Mao Y; Zhao L
Aging (Albany NY); 2022 Aug; 14(15):6269-6298. PubMed ID: 35963644
[TBL] [Abstract][Full Text] [Related]
3. Identification of ACSF gene family as therapeutic targets and immune-associated biomarkers in hepatocellular carcinoma.
Zhao Z; Liu M; Xu Z; Cai Y; Peng B; Liang Q; Yan Y; Liu W; Kang F; He Q; Hong Q; Zhang W; Li J; Peng J; Zeng S
Aging (Albany NY); 2022 Oct; 14(19):7926-7940. PubMed ID: 36205594
[TBL] [Abstract][Full Text] [Related]
4. SOX11 hypermethylation as a tumor biomarker in endometrial cancer.
Shan T; Uyar DS; Wang LS; Mutch DG; Huang TH; Rader JS; Sheng X; Huang YW
Biochimie; 2019 Jul; 162():8-14. PubMed ID: 30935961
[TBL] [Abstract][Full Text] [Related]
5. Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment.
Yin Z; Ma T; Chen S; Yu M
Cancer Biomark; 2023; 36(3):231-250. PubMed ID: 36938723
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis of SOXF family genes reveals potential regulatory mechanism and diagnostic value in cancers.
Wu D; Jiang C; Zheng JJ; Luo DS; Ma J; Que HF; Li C; Ma C; Wang HY; Wang W; Xu HT
Ann Transl Med; 2022 Jun; 10(12):701. PubMed ID: 35845531
[TBL] [Abstract][Full Text] [Related]
7. MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma.
Zhou L; Chen G; Liu T; Liu X; Yang C; Jiang J
Front Genet; 2022; 13():965805. PubMed ID: 36159990
[TBL] [Abstract][Full Text] [Related]
8. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast Growth Factor 19-Mediated Up-regulation of SYR-Related High-Mobility Group Box 18 Promotes Hepatocellular Carcinoma Metastasis by Transactivating Fibroblast Growth Factor Receptor 4 and Fms-Related Tyrosine Kinase 4.
Chen J; Du F; Dang Y; Li X; Qian M; Feng W; Qiao C; Fan D; Nie Y; Wu K; Xia L
Hepatology; 2020 May; 71(5):1712-1731. PubMed ID: 31529503
[TBL] [Abstract][Full Text] [Related]
11. Multi-Omics Analysis of
Seok J; Gil M; Dayem AA; Saha SK; Cho SG
J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442467
[TBL] [Abstract][Full Text] [Related]
12. The relationship among Girdin DNA methylation, its high expression, and immune infiltration in hepatocellular carcinoma: Clues from in silico analysis.
Zhang C; Ke Y; Lei X; Liu X; Li H; Shi R; Wang L
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33660763
[TBL] [Abstract][Full Text] [Related]
13. The role of SOX family members in solid tumours and metastasis.
Grimm D; Bauer J; Wise P; Krüger M; Simonsen U; Wehland M; Infanger M; Corydon TJ
Semin Cancer Biol; 2020 Dec; 67(Pt 1):122-153. PubMed ID: 30914279
[TBL] [Abstract][Full Text] [Related]
14. Sox transcription factors require selective interactions with Oct4 and specific transactivation functions to mediate reprogramming.
Aksoy I; Jauch R; Eras V; Chng WB; Chen J; Divakar U; Ng CK; Kolatkar PR; Stanton LW
Stem Cells; 2013 Dec; 31(12):2632-46. PubMed ID: 23963638
[TBL] [Abstract][Full Text] [Related]
15. YTH domain family: potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma.
Liu M; Zhao Z; Cai Y; Bi P; Liang Q; Yan Y; Xu Z
Aging (Albany NY); 2021 Nov; 13(21):24205-24218. PubMed ID: 34747720
[TBL] [Abstract][Full Text] [Related]
16.
Lu J; An SG; Ma JJ; Yang Y; Zhang L; Yu P; Tao H; Chen YF; Zhang HX
Chin Med Sci J; 2022 Dec; 37(4):331-339. PubMed ID: 36647592
[TBL] [Abstract][Full Text] [Related]
17. Identification of SOX6 and SOX12 as Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma: A Retrospective Study Based on TCGA Database.
Lyu X; Zhang X; Sun LB; Cao XM; Zhang XH
Dis Markers; 2021; 2021():7190301. PubMed ID: 34868396
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C
Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of SOX2, SOX3, SOX11, SOX14 and SOX18 gene expression in adult de novo acute myeloid leukemia.
Tosic N; Petrovic I; Grujicic NK; Davidovic S; Virijevic M; Vukovic NS; Pavlovic S; Stevanovic M
Leuk Res; 2018 Apr; 67():32-38. PubMed ID: 29428447
[TBL] [Abstract][Full Text] [Related]
20. Identification of G6PC as a potential prognostic biomarker in hepatocellular carcinoma based on bioinformatics analysis.
Tian L; Liao Y
Medicine (Baltimore); 2022 Aug; 101(33):e29548. PubMed ID: 35984176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]